Elanco Animal Health (ELAN) Goodwill & Intangibles (2017 - 2026)
Elanco Animal Health (ELAN) posted Goodwill & Intangibles of $7.9 billion for Q1 2026, down 2.92% sequentially from $8.2 billion in Q4 2025, and down 2.38% YoY from $8.1 billion in Q1 2025.
Elanco Animal Health (ELAN) Goodwill & Intangibles (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Goodwill & Intangibles for 10 years, with the latest figure at $7.9 billion in Q1 2026.
- Quarterly Goodwill & Intangibles fell 2.38% year-over-year to $7.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.9 billion (down 2.38% YoY) and the FY2025 annual result came in at $8.2 billion, up 1.14% from the prior year.
- Goodwill & Intangibles slipped to $7.9 billion in Q1 2026 per ELAN's latest filing, from $8.2 billion in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $11.5 billion in Q1 2022 and troughed at $7.9 billion in Q1 2026.
- A 5-year average of $9.4 billion and a median of $8.7 billion in 2024 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles declined 20.88% in 2024, then increased 1.14% in 2025.
- Over 5 years, Goodwill & Intangibles stood at $10.8 billion in 2022, then retreated by 11.51% to $9.6 billion in 2023, then slipped by 15.57% to $8.1 billion in 2024, then advanced by 1.14% to $8.2 billion in 2025, then decreased by 2.92% to $7.9 billion in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $7.9 billion, $8.2 billion, and $8.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.05 Bn |
| Mar 31, 2026 | 7.95 Bn |
| Dec 31, 2025 | 8.19 Bn |
| Sep 30, 2025 | 8.36 Bn |
| Jun 30, 2025 | 8.46 Bn |
| Mar 31, 2025 | 8.14 Bn |
| Dec 31, 2024 | 8.10 Bn |
| Sep 30, 2024 | 8.64 Bn |
| Jun 30, 2024 | 8.48 Bn |
| Mar 31, 2024 | 8.67 Bn |
| Dec 31, 2023 | 9.59 Bn |
| Sep 30, 2023 | 9.38 Bn |
| Jun 30, 2023 | 10.72 Bn |
| Mar 31, 2023 | 10.85 Bn |
| Dec 31, 2022 | 10.84 Bn |
| Sep 30, 2022 | 10.48 Bn |
| Jun 30, 2022 | 10.96 Bn |
| Mar 31, 2022 | 11.51 Bn |
| Dec 31, 2021 | 11.76 Bn |
| Sep 30, 2021 | 12.01 Bn |